0000930775 false 0000930775 2022-11-15 2022-11-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 17, 2022 (November 15, 2022)

 

ENCISION, INC.

(Exact name of registrant as specified in its charter)

Colorado 001-11789 84-1162056
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
     
6797 Winchester Circle, Boulder, Colorado 80301
(Address of principal executive offices)

(Zip Code)

 

(303) 444-2600
(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, no par value   ECIA   OTC Bulletin Board

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 
 
 
Item 1.01Entry into a Material Definitive Agreement.

 

On November 15, 2022, Encision Inc. (“Encision” or the “Company”) entered into a loan and security agreement with Pathward, N.A. (formerly Crestmark Bank). The loan is due on demand and has no financial covenants. Under the agreement, we were provided with a line of credit that is not to exceed the lesser of $1,000,000 or 85% of eligible accounts receivable. The interest rate is prime rate plus 0.5%, with a floor of 6.75%, plus a monthly maintenance fee of 0.4%, based on the average monthly loan balance. Interest is charged on a minimum loan balance of $300,000, a loan fee of 0.5% at closing and annually, and an exit fee of 3%, 2% and 1% during years one, two and three, respectively.

 

Item 9.01.

 

(d) Exhibits.

 

Financial Statements and Exhibits.

Exhibit Number

 

Description
10.1 Loan Agreement with Pathward, N.A. dated November 15, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

  

 

 

 

 

 

 
 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ENCISION, INC.
  (Registrant)
   
Date:  November 17, 2022  
  /s/ Mala M Ray
  Mala M Ray
  Controller
  Principal Accounting Officer

 

Exhibit 10.1